Global Peptic Ulcer Drugs Markets Report 2021: Market to Reach $5.9 Billion by 2027 – Focus on Proton Pump Inhibitors (PPIs), Gastric Mucosal Protective Drugs, H2 Receptor Antagonists – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Peptic Ulcer Drugs – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.
Global Peptic Ulcer Drugs Market to Reach $5.9 Billion by 2027
Amid the COVID-19 crisis, the global market for Peptic Ulcer Drugs estimated at US$4.9 Billion in the year 2020, is projected to reach a revised size of US$5.9 Billion by 2027, growing at a CAGR of 2.6% over the analysis period 2020-2027.
Proton Pump Inhibitors (PPIs), one of the segments analyzed in the report, is projected to record a 2.5% CAGR and reach US$4.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Gastric Mucosal Protective Drugs segment is readjusted to a revised 3.3% CAGR for the next 7-year period.
The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 2.5% CAGR
The Peptic Ulcer Drugs market in the U.S. is estimated at US$1.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1 Billion by the year 2027 trailing a CAGR of 2.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.4% and 2.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.
H2 Receptor Antagonists Segment to Record 2.8% CAGR
In the global H2 Receptor Antagonists segment, USA, Canada, Japan, China and Europe will drive the 2.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$374.3 Million in the year 2020 will reach a projected size of US$458 Million by the close of the analysis period.
China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$652.8 Million by the year 2027.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS (Total 46 Featured):
- Abbott Laboratories
- AstraZeneca PLC
- Cadila Healthcare Ltd. (Zydus Cadila)
- Daewoong Pharmaceutical Co., Ltd.
- Eisai Co., Ltd.
- Pharmaking Co., Ltd.
- Taiho Pharmaceutical Co., Ltd.
- Takeda Pharmaceutical Co., Ltd.
- Yuhan Corporation
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
- World 15-Year Perspective for Peptic Ulcer Drugs by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
- World 15-Year Perspective for Proton Pump Inhibitors (PPIs) by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- World 15-Year Perspective for Gastric Mucosal Protective Drugs by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- World 15-Year Perspective for H2 Receptor Antagonists by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
- World 15-Year Perspective for Other Segments by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
III. GEOGRAPHIC MARKET ANALYSIS
IV. COMPETITION
- Total Companies Profiled: 46
For more information about this report visit https://www.researchandmarkets.com/r/kp6xwj
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
